AR232000A1 - Procedimiento para la obtencion de pancreatina - Google Patents

Procedimiento para la obtencion de pancreatina

Info

Publication number
AR232000A1
AR232000A1 AR295280A AR29528083A AR232000A1 AR 232000 A1 AR232000 A1 AR 232000A1 AR 295280 A AR295280 A AR 295280A AR 29528083 A AR29528083 A AR 29528083A AR 232000 A1 AR232000 A1 AR 232000A1
Authority
AR
Argentina
Prior art keywords
procedure
pancreatin
obtaining
obtaining pancreatin
Prior art date
Application number
AR295280A
Other languages
English (en)
Spanish (es)
Original Assignee
Nordmark Werke Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19823248587 external-priority patent/DE3248587A1/de
Priority claimed from DE19823248588 external-priority patent/DE3248588A1/de
Application filed by Nordmark Werke Gmbh filed Critical Nordmark Werke Gmbh
Application granted granted Critical
Publication of AR232000A1 publication Critical patent/AR232000A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/94—Pancreatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AR295280A 1982-12-30 1983-12-28 Procedimiento para la obtencion de pancreatina AR232000A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823248587 DE3248587A1 (de) 1982-12-30 1982-12-30 Verfahren zur gewinnung von pankreatin
DE19823248588 DE3248588A1 (de) 1982-12-30 1982-12-30 Verfahren zur gewinnung von pankreatin von hohem schuettgewicht

Publications (1)

Publication Number Publication Date
AR232000A1 true AR232000A1 (es) 1985-04-30

Family

ID=25807022

Family Applications (1)

Application Number Title Priority Date Filing Date
AR295280A AR232000A1 (es) 1982-12-30 1983-12-28 Procedimiento para la obtencion de pancreatina

Country Status (15)

Country Link
US (1) US4623624A (uk)
EP (1) EP0115023B1 (uk)
AR (1) AR232000A1 (uk)
BR (1) BR8307280A (uk)
CA (1) CA1208580A (uk)
DD (1) DD212981A5 (uk)
DE (1) DE3377506D1 (uk)
DK (1) DK173599B1 (uk)
ES (1) ES8407516A1 (uk)
HU (1) HU196435B (uk)
MD (1) MD411C2 (uk)
PL (1) PL141118B1 (uk)
SU (1) SU1644712A3 (uk)
UA (1) UA5996A1 (uk)
YU (1) YU45584B (uk)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2030581C (en) * 1989-11-24 2000-06-27 Gunther Atzl Pancreatin preparations
CA2198317C (en) * 1997-02-24 2003-01-07 Mouhsine El Abboudi Method for preparing pancreatin which contains low amounts of residual organic solvent and product thereof
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
KR100367659B1 (ko) * 2000-05-08 2003-01-14 주식회사 바이넥스 선택적 안정화제의 첨가에 따른 자가분해(autolysis)를 통한 고역가 판크레아틴의 제조방법
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
CA2419572A1 (en) * 2003-02-18 2004-08-18 Axcan Pharma Inc. High dosage protease formulation
CN1809753B (zh) * 2003-07-29 2010-10-20 索尔瓦药物有限公司 通过二维凝胶电泳分析包含生理可接受消化酶混合物的方法
AU2005227090B2 (en) * 2004-03-22 2010-12-09 Abbott Laboratories Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
US7153504B2 (en) * 2004-07-30 2006-12-26 Can Technologies, Inc. Stabilized pancreas product
BRPI0611535B1 (pt) 2005-05-05 2021-11-30 Sensient Flavors Inc Método para processar células de levedura para produzir beta-glucanos e mananas
UA93384C2 (uk) 2005-07-29 2011-02-10 Солвей Фармасьютикалс Гмбх Спосіб одержання стерилізованого порошкоподібного панкреатину
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
TW200745337A (en) * 2006-02-24 2007-12-16 Aminotech As Modified process
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
WO2008102264A2 (en) 2007-02-20 2008-08-28 Eurand Pharmaceuticals Limited Stable digestive enzyme compositions
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
WO2010002972A1 (en) * 2008-07-01 2010-01-07 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
EP2165717A1 (de) * 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
EP2947100B1 (en) 2009-01-06 2019-05-08 Galenagen, LLC Oral compositions for the treatment or the prevention of infections by E. Coli
BRPI1007378A2 (pt) 2009-01-06 2020-08-18 Curemark Llc composições e métodos para o tratamento ou prevenção de infecções por staphylococcus aureus e para a erradicação ou redução de staphylococcus aureus sobre superfícies.
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
CL2011002432A1 (es) 2010-10-01 2012-04-20 Aptalis Pharma Ltd Composicion que comprende al menos una enzima digestiva y al menos un portador, en donde el portador comprende celulosa microcristalina que tiene un tamaño de particulas mayor que 100 um; una forma de dosificacion; el envase que la contiene; un proceso para preparar la composicion; y sus usos.
HUE050873T2 (hu) 2011-04-21 2021-01-28 Curemark Llc Vegyületek neuropszichiátriai rendellenességek kezelésére
ES2734221T3 (es) 2011-08-08 2019-12-04 Allergan Pharmaceuticals Int Ltd Método para la prueba de disolución de composiciones sólidas que contienen enzimas digestivas
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
BR112016001289A2 (pt) * 2013-07-22 2018-03-20 Allergan Pharmaceuticals International Limited pancreatina de alta atividade (ha-pancreatina), composição farmacêutica de alta potência, processo para preparação da ha-pancreatina com atividade de lipase específica de, pelo menos, cerca de 120 ui usp/mg e método de tratamento de um paciente que apresenta uma condição fisiológica associada à insuficiência enzimática pancreática
JP2016537387A (ja) 2013-08-09 2016-12-01 アラガン ファーマシューティカルズ インターナショナル リミテッド 経腸投与に適した消化酵素組成物
KR20170052520A (ko) * 2013-11-05 2017-05-12 앨러간 파마슈티컬스 인터내셔널 리미티드 고효능 판크레아틴 약학적 조성물
MX2016016907A (es) 2014-06-19 2018-04-26 Aptalis Pharma Ltd Metodo para eliminar contaminantes virales de extractos pancreaticos.
MX2017005941A (es) 2014-11-05 2018-02-13 Abbott Laboratories Gmbh Procesos para la producción de composiciones con perfil de seguridad mejorado teniendo actividad lipasa y composiciones adecuadas para medicamentos.
CN109475610A (zh) 2016-03-28 2019-03-15 雅培制药股份有限公司 病毒和微生物污染减少的酶组合物
US11278603B2 (en) 2016-03-28 2022-03-22 Abbvie Inc. Enzyme compositions with reduced viral and microbial contamination
EA202090851A1 (ru) 2017-09-27 2020-08-07 Эбботт Лэбораториз Гмбх Ферментные композиции со сниженным уровнем вирусного и микробного загрязнения
CN108316036A (zh) * 2018-01-25 2018-07-24 陕西科技大学 一种豆渣制备微纤化纤维素的方法
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
WO2024105193A1 (en) * 2022-11-17 2024-05-23 Koptyug Andrey V Novel compounds and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB928654A (en) * 1960-10-25 1963-06-12 Philips Nv Improvements in or relating to the production of pancreatin
GB1328202A (en) 1969-06-17 1973-08-30 Union International Co Ltd Manufacture of pancreatin
DE2106706B2 (de) * 1971-02-12 1973-05-10 Wilson Pharmaceutical & Chemical Corp., Chicago, 111. (V.St.A.) Verfahren zur herstellung von pankreatin als trockenes pulver mit hoher proteolytischer, amylolytischer und lipolytischer aktivitaet
MX4738E (es) 1976-05-07 1982-08-25 Nattermann A & Cie Procedimiento para fabricar preparados enzimaticos ricos en lipasa
DE2620289C2 (de) * 1976-05-07 1982-05-19 A. Nattermann & Cie GmbH, 5000 Köln Herstellung eines lipasereichen Enzympräparates

Also Published As

Publication number Publication date
DK605583D0 (da) 1983-12-29
ES528537A0 (es) 1984-09-16
BR8307280A (pt) 1984-08-07
DD212981A5 (de) 1984-08-29
SU1644712A3 (ru) 1991-04-23
DE3377506D1 (en) 1988-09-01
ES8407516A1 (es) 1984-09-16
US4623624A (en) 1986-11-18
EP0115023A3 (en) 1986-04-09
EP0115023A2 (de) 1984-08-08
EP0115023B1 (de) 1988-07-27
DK173599B1 (da) 2001-04-23
PL245381A1 (en) 1984-10-22
CA1208580A (en) 1986-07-29
YU45584B (sh) 1992-07-20
HU196435B (en) 1988-11-28
MD411C2 (ro) 1996-06-30
DK605583A (da) 1984-07-01
PL141118B1 (en) 1987-06-30
UA5996A1 (uk) 1994-12-29
YU252483A (en) 1986-10-31

Similar Documents

Publication Publication Date Title
AR232000A1 (es) Procedimiento para la obtencion de pancreatina
ES555049A0 (es) Procedimiento para la obtencion de arilciclopropil-cetonas
ES527714A0 (es) Procedimiento para la obtencion de tetrapeptidos sustituidos
ES543386A0 (es) Procedimiento para la obtencion de 1-heteroaril-4-aril-pira-zolin-5-onas
ES542207A0 (es) Procedimiento para la obtencion de tetrahidrofuran-2-ilmeti-laminas
ES533538A0 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
ES520273A0 (es) Procedimiento para la obtencion de trimetilolpropano.
ES550219A0 (es) Procedimiento para la obtencion de aminopolieteres alcoxi- lados
ES545967A0 (es) Procedimiento para la obtencion de poliarilensulfuro
ES516841A0 (es) Procedimiento para la obtencion de benzofuranonas
ES549255A0 (es) Procedimiento para la obtencion de halogeno-hidroxi-flavonas
ES526042A0 (es) Procedimiento para la obtencion de azolilbutanoles
ES543820A0 (es) Procedimiento para la obtencion de piperacinil-oxo-quinoli- nas
ES533988A0 (es) Procedimiento para la obtencion de mercaptocarboxilamidas
ES525257A0 (es) Procedimiento para la obtencion de poliamido-imidas
ES549266A0 (es) Procedimiento para la obtencion de n-halo-carbonil-fenilhi- drazinas substituidas
ES522474A0 (es) Procedimiento para la obtencion de halogenopropargilformamidas.
ES546549A0 (es) Procedimiento para la obtencion de fluoralcoxifenilsulfonil-guanidinas
ES526672A0 (es) Procedimiento para la obtencion de latex cationicos
ES519809A0 (es) Procedimiento para la obtencion de oxazolidin-2-onas.
ES537129A0 (es) Procedimiento para la obtencion de iodacetamidas
ES546192A0 (es) Procedimiento para la obtencion de benzotiazolsulfenamidas
ES525507A0 (es) Procedimiento para la obtencion de 2-benzotiazolsulfenamidas estericamente impedidas
ES525995A0 (es) Procedimiento de obtencion de piridopirimidinonas
ES555531A0 (es) Procedimiento para la obtencion de benzotiopiranonas